Clinical Performance of the Diassess Influenza A and B Test

VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old

NCT00973895 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Psychometric Testing Properties of Severity Symptom Grading Scale of Influenza Infection: Flu-PRO Stage III

NCT02302924 ·Status: COMPLETED

Rapid Diagnostic Test for Influenza

NCT01089816 ·Status: COMPLETED

A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults

NCT05333289 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase 1 Placebo-controlled,Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of MEDI8852 in Adults

NCT02350751 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly Subjects

NCT00354016 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older

NCT00329966 ·Status: COMPLETED ·Phase: PHASE2

Influenza A H3N2 Human Challenge Study in Healthy Adult Volunteers

NCT02594189 ·Status: COMPLETED ·Phase: PHASE1

A Pilot Study for Collection of Anti-Influenza A Immune Plasma

NCT00984451 ·Status: COMPLETED

Assessment of the Clinical Performance of the ARROW-FLU System

NCT02996136 ·Status: UNKNOWN ·Phase: NA

A Clinical Study to Assess the Safety of a New Influenza Vaccine

NCT01104493 ·Status: COMPLETED ·Phase: PHASE4

Dose, Safety, Tolerability and Immunogenicity of an Influenza H10 Stabilized Stem Ferritin Vaccine, VRC-FLUNPF0103-00-VP, in Healthy Adults

NCT04579250 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects

NCT01422512 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to Non-elderly Adult and Elderly Subjects

NCT01357265 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers

NCT02385123 ·Status: TERMINATED ·Phase: PHASE4

A/H5N1 Vaccine in Healthy Children Aged 2-9 Years

NCT00133536 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Th1 Response to Influenza: Aging and Vaccine Efficacy

NCT00396305 ·Status: TERMINATED ·Phase: PHASE4

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Non-Elderly Adult and Elderly Subjects

NCT01356316 ·Status: COMPLETED ·Phase: PHASE4

A/H1N1 Immunogenicity and Safety in Adults

NCT00959465 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects

NCT00522236 ·Status: COMPLETED ·Phase: PHASE2

QuickVue Influenza A + B Test Field Study

NCT03417869 ·Status: COMPLETED

Blood and Plasma Collection For Use in Future Clinical Trials

NCT01136057 ·Status: COMPLETED

PET-CT Scans in Healthy Volunteers After Flu Vaccination

NCT00769002 ·Status: TERMINATED ·Phase: NA

The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults

NCT05523089 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age

NCT02839330 ·Status: COMPLETED ·Phase: PHASE3